Losartan and kidney disease
Pro Research Analysisby 
Searched over 200M research papers
Losartan and Kidney Disease: A Comprehensive Overview
Introduction to Losartan and Kidney Disease
Losartan, an angiotensin II receptor antagonist, is widely used to manage hypertension and protect kidney function, particularly in patients with diabetes and chronic kidney disease (CKD). This article synthesizes findings from multiple studies to highlight the effects of losartan on renal outcomes, especially in diabetic nephropathy and other forms of CKD.
Losartan in Diabetic Nephropathy
Renal Benefits in Type 2 Diabetes
Several studies have demonstrated the renoprotective effects of losartan in patients with type 2 diabetes and nephropathy. A significant study involving 1513 patients showed that losartan reduced the incidence of doubling serum creatinine concentration by 25% and end-stage renal disease (ESRD) by 28% compared to placebo, without affecting the mortality rate . Additionally, losartan significantly decreased proteinuria by 35%, indicating its potential to slow the progression of renal disease beyond its blood pressure-lowering effects .
Long-term Effects in American Indians
A follow-up analysis of a 6-year clinical trial involving American Indians with type 2 diabetes revealed that early administration of losartan did not significantly slow the long-term decline in glomerular filtration rate (GFR) compared to placebo . However, another study in the same population indicated that losartan might preserve kidney structure in patients with microalbuminuria, suggesting some renoprotective benefits in early diabetic nephropathy .
Comparative Studies with Other Antihypertensives
Losartan vs. Amlodipine
In a 12-month study comparing losartan with the calcium channel blocker amlodipine in patients with proteinuric CKD and hypertension, losartan significantly reduced urinary protein excretion, whereas amlodipine did not . This reduction in proteinuria was evident regardless of the level of blood pressure control, highlighting losartan's specific renoprotective properties .
Combination Therapy with Aliskiren
A study evaluating the addition of aliskiren, a direct renin inhibitor, to losartan therapy in patients with type 2 diabetes and nephropathy found that the combination significantly reduced the urinary albumin-to-creatinine ratio by 20% compared to losartan alone . This suggests that dual blockade of the renin-angiotensin-aldosterone system may offer additional renal benefits.
Economic Impact of Losartan
The RENAAL study's economic evaluation demonstrated that losartan not only reduced the incidence of ESRD but also resulted in substantial cost savings. The study estimated a reduction of 33.6 days with ESRD per patient over 3.5 years, translating to a net savings of $3522 per patient after accounting for the cost of losartan .
Safety and Adverse Effects
Combination Therapy Risks
While combination therapy with angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) like losartan can decrease proteinuria, it also increases the risk of adverse events such as hyperkalemia and acute kidney injury. A study involving combination therapy with losartan and lisinopril was stopped early due to these safety concerns .
Acute GFR Changes
An acute fall in GFR during the initial phase of losartan treatment has been associated with a slower long-term decline in renal function. This suggests that the initial drop in GFR may reflect a beneficial hemodynamic effect, leading to better long-term renal outcomes .
Conclusion
Losartan has demonstrated significant renoprotective effects in patients with type 2 diabetes and CKD, particularly in reducing proteinuria and slowing the progression to ESRD. While combination therapies may offer additional benefits, they also pose increased risks of adverse events. The economic benefits of losartan further support its use in managing diabetic nephropathy. However, individual patient responses and safety profiles should guide therapy decisions.
Sources and full results
Most relevant research papers on this topic